Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea
Incannex announced the official commencement of its DReAMzz clinical study evaluating IHL-42X for obstructive sleep apnea, with clinical sites identified and trial infrastructure activated.
Trial Start • Phase 2/3Trial commencement announcement Thu, May 14, 2026